Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Polaris Group

Clinical trials sponsored by Polaris Group, explained in plain language.

Polaris Group 6550 TWSE

Biopharmaceutical company developing cancer therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Terminated 1

Experimental drug combo for rare sarcoma shows promise, but trial halted early

Disease control Terminated

This phase 3 trial tested whether adding ADI-PEG 20 to standard chemotherapy (gemcitabine and docetaxel) could help people with advanced leiomyosarcoma, a rare soft tissue cancer. The study planned to enroll 218 participants whose cancer had progressed after prior treatment. Unfo…

Phase: PHASE3 • Sponsor: Polaris Group • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC